Advertisement

Loading...

GeneTether Therapeutics Inc.

GTTX.CN•CNQ
Healthcare
Biotechnology
$0.12
$0.00(0.00%)
Canadian Market is Open • 15:53

GeneTether Therapeutics Inc. (GTTX.CN) Stock Overview

Explore GeneTether Therapeutics Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap4.6M
P/E Ratio-5.81
EPS (TTM)$-0.01
ROE-0.43%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.13

GTTX.CN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of GeneTether Therapeutics Inc. (GTTX.CN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.13.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -5.81 and a market capitalization of 4.6M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
-7.69%
1-Month Change
33.33%
3-Month Change
700.00%
6-Month Change
140.00%
Year-to-Date (YTD) Change
33.33%
1-Year Change
140.00%
3-Year Change
-82.35%
5-Year Change
-82.35%
All-Time (Max) Change
-82.35%

Contact Information

https://genetether.com
NaN
301 – 1665 Ellis Street, Kelowna, BC, V1Y 2B3

Company Facts

IPO DateMar 30, 2022
CountryCA

Frequently Asked Questions